Hrushikesh Vyas / LinkedIn
Jul 17, 2026, 09:57
Hrushikesh Vyas: Presenting Inherited Thrombocytopenia Research at ISTH 2026
Hrushikesh Vyas, CRUK Clinical Research Training Fellow, Haematology Doctor – ST4, shared a post on LinkedIn:
“Had a wonderful time at International Society on Thrombosis and Haemostasis (ISTH) congress in Paris learning and engaging with experts from the field of haemostasis and thrombosis.
It was a great experience to present our work on the use of dasatinib as a novel treatment for SRC-Related Thrombocytopenia in the session on the clinical implications of inherited thrombocytopenias. Thank you to all those that attended and engaged!
Thank you to my supervisors Prof Neil Morgan, Dr Gillian Lowe and Dr Manoj Raghavan for their support and guidance.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 02:37M. Sekip Altunkan: Can Anticoagulation Be Safely Stopped After AF Ablation?
-
Oct 20, 2026, 02:26Ahmed Ammar: Managing VT Recurrence Post-Ablation
-
Oct 20, 2026, 01:43Oliver Weingärtner: Deprescribing of Lipid Lowering Drug after MI is Associated with Cardiovascular Events
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA